https://www.gosh.nhs.uk/news/gosh-receives-over-35m-for-research-and-innovation/
GOSH receives over £3.5m for research and innovation
28 Jun 2023, 11:31 a.m.
GOSH has been awarded over £3.5m by the National Institute of Health and Care Research (NIHR) for vital research and innovation equipment that will help to improve treatments for children.
The funding is part of a wider £96m award to 93 NHS organisations across England, which are all part of the NIHR’s wider infrastructure. This includes Biomedical Research Centres and Clinical Research Facilities, as well as NIHR’s Clinical Research Network.
The new equipment that will be purchased for our hospital includes state-of-the-art microscopes, a liquid nitrogen generator, a genomic sequencer and a specialised 3D-printer that can print medicines. It also included some more fundamental equipment such as trolleys, computers and data storage.
Many of our research platforms are running at full capacity with long waiting times due to a lack of equipment availability. This additional investment is really welcome and will facilitate faster translation of our research into the clinic, and ultimately help more patients.
A visit from the Health and Social Care Secretary
To tie in with the announcement, the Health and Social Care Secretary Steve Barclay, Steve Barclay MP, visited our hospital. He met a patient family involved in a research trial, and staff from across the hospital which showcased the difference that research and innovation is making to patients and families.
Health and Social Care Secretary Steve Barclay said:
“The NHS and its staff have now served us for nearly 75 years and as we celebrate that achievement we want to make sure the health service is leading the way. This investment will also help the NHS continue to cut waiting lists – one of the government’s top five priorities.”
Our aim at GOSH is to embed research and innovation at every level, involving all of our staff, so it’s fantastic that our proposal to distribute this large award across teams that support work right across the hospital can now be implemented – from nitrogen generators to genomic sequencing. This will support us to deliver research and innovation that will impact the lives of patients here at GOSH and far beyond.
We are delighted to have received the full list of equipment that we bid for and for the great feedback on our plans. This further investment from the NIHR will help to strengthen our ambitious plans for the next 5 years of the NIHR GOSH Biomedical Research centre, remain abreast of technology development and translate research into new therapies for children with rare and complex diseases.
NIHR GOSH Clinical Research Facility celebrates patients and their families with a festive celebration
On Wednesday 18 December we celebrated the festive period at the National Institute for Health Research (NIHR) GOSH Clinical Research Facility (CRF) on the 8th floor of the Southwood building.
Duchenne Muscular Dystrophy gene therapy trial highlights complexity of disease
The first large-scale trial of gene therapy for the debilitating neuromuscular disease, Duchenne Muscular Dystrophy (DMD) has been carried out
New findings from world’s largest study on children with Long-Covid
A new study led by clinicians and researchers at Great Ormond Street Hospital and University College London Great Ormond Street Institute of Child Health has found that 70% of young people in England with Long-Covid recover within two years.
GOSH celebrates its fifth academic training weekend
In early November 70 early career researchers came together for the fifth NIHR GOSH BRC Academic Training Weekend.